Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.

Hair RiseTM microemulsion effectively promotes hair growth and treats hair loss better than standard treatments.

Some treatments for hereditary hair loss are effective but vary in results and side effects; new therapies show promise but need more research.

Oral contraceptives can help manage acne by reducing androgen levels.

Testosterone may influence COVID-19 severity and outcomes.

Treatments for PCOS aim to reduce androgen levels and improve insulin sensitivity to lower cardiometabolic risk.

The link between anabolic agents and colorectal cancer risk is unclear.

A specific pathway involving AR, miR-221, and IGF-1 plays a key role in causing common hair loss.

Male-pattern hair loss is largely influenced by genetics, with key genes identified.

Weak endocrine disruptors in mixtures can have significant effects and should be considered in risk assessments.

Anabolic androgenic steroids can increase cancer risk and disrupt hormones.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

The normal human prostate does not significantly affect blood DHT levels.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Testosterone helps prevent skin damage in males by acting through both estrogen and androgen pathways.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

The compound 16 from the Merremia peltata plant could potentially be a good treatment for hair loss (alopecia) due to its strong activity and favorable skin absorption.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Hormonal therapies can improve skin issues by adjusting hormone levels, with future advancements promising better results.

Targeting the p300/AR axis may help treat polycystic ovary syndrome.

Combining minoxidil with ginsenoside Rg3 and glycyrrhizic acid offers a more effective treatment for androgenic alopecia.

New treatments for androgenetic alopecia show promise but need more research for validation.

New drug strategies are needed for better hair loss treatments.

HA-stimulated stem cell vesicles improved hair growth in male mice with androgenetic alopecia.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Androgenetic alopecia in men is genetic and linked to health issues like obesity and heart disease, with treatments including minoxidil, finasteride, and hair transplants.

A substance called Cell-free fat extract can effectively treat common hair loss by increasing hair growth and density.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Male pattern hair loss may be linked to the developmental origins of hair follicles.